Literature DB >> 6795753

UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.

M J Randall, M J Parry, E Hawkeswood, P E Cross, R P Dickinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795753     DOI: 10.1016/0049-3848(81)90247-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  21 in total

1.  Mechanisms of bradykinin-induced contraction of the guinea-pig gallbladder in vitro.

Authors:  D A Cabrini; A M Silva; J B Calixto
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

2.  Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.

Authors:  M O Aksoy; C Harakal; J B Smith; G J Stewart; C R Zerweck
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

3.  Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.

Authors:  D S Houston; J T Shepherd; P M Vanhoutte
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  Sequential histamine inhalations cause increased bronchial histamine reactivity in guinea pigs: role of platelets, thromboxanes and prostacyclin.

Authors:  W Dorsch; C Hintschich; J Neuhauser; J Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

5.  Pathophysiological mechanisms of sudden death induced by platelet activating factor.

Authors:  A M Lefer; H F Müller; J B Smith
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

6.  Dazoxiben: a pharmacological tool or clinical candidate?

Authors:  H M Tyler
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat.

Authors:  M Tissot; C Bonne; B Martin; M Solier; J P Giroud
Journal:  Agents Actions       Date:  1984-01

Review 8.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

9.  Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.

Authors:  R Winn; J Harlan; B Nadir; L Harker; J Hildebrandt
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

10.  Dazoxiben examined for platelet inhibitory effect in an artificial circulation.

Authors:  M Goldman; C Hall; R J Hawker; C N McCollum
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.